Answers are grounded in this paper and cite their sources.
This narrative review examines exocrine gland dysfunction in Parkinson's disease, suggesting improved management and biomarker discovery.
Exocrine gland dysfunction represents a prevalent, intricate, and clinically significant range of non-motor symptoms in PD, indicative of extensive autonomic involvement. Early detection may enhance quality of life and symptom management while also offering insights into disease mechanisms, the discovery of biomarkers and therapeutic interventions.
No takes yet. Share an insight, caveat, or question.
Munhoz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: